Research statistics
P21 (BDNF-mimetic peptide) research: publications and trials
At a glance
Publications, all years
13
Since 2014
Publications in 2026 so far
1
Through November 15, 2026
Human clinical research
0.0%
0 of 13 classified
Registered clinical trials
0
ClinicalTrials.gov
Randomized controlled trials
0
Publications reporting an RCT in people
Systematic reviews and meta-analyses
0
Preclinical studies
84.6%
11 animal · 0 in vitro · 0 computational
Records that only mention it
18
Not counted above
Status in the library: Research only. Groups: Cognitive and neurological peptides.
What to keep in mind
- No human clinical publication is indexed: everything published so far is preclinical, a review or commentary.
- Fewer than three randomized controlled trials are indexed.
- More than 70% of the indexed publications are animal, cell or computational studies.
- Fewer than 25 publications are indexed, so year-to-year changes are not meaningful.
Publications by year
P21 (BDNF-mimetic peptide) publications by year and evidence
Show the data
| Year | Preclinical (animal, in vitro, computational) | Reviews and meta-analyses | Total |
|---|---|---|---|
| 2014 | 2 | 0 | 2 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 3 | 0 | 3 |
| 2019 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
| 2021 | 1 | 0 | 1 |
| 2022 | 0 | 1 | 1 |
| 2024 | 1 | 0 | 1 |
| 2026 (to date) | 1 | 0 | 1 |
Study types
| Animal study | 11 |
|---|---|
| Review | 2 |
Research areas
From MeSH major topics. A paper can be in several areas.
| Neurological and mental health | 13 |
|---|---|
| Cognitive health | 11 |
| Longevity and aging | 2 |
| Reproductive and sexual health | 1 |
Registered clinical trials
A registration is not a result.
No registered trials.
Human trials and evidence reviews
Meta-analyses, systematic reviews and trials in people, newest first.
No human trial, systematic review or meta-analysis of P21 (BDNF-mimetic peptide) is indexed.
Most cited
By OpenAlex citation count. Citations measure attention, not quality or correctness.
- Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Molecular neurodegeneration · July 11, 2016 · Review · cited 116 times · open access
PMID 27400746 · DOI 10.1186/s13024-016-0119-y · Reviews and meta-analyses
- Disease modifying effect of chronic oral treatment with a neurotrophic peptidergic compound in a triple transgenic mouse model of Alzheimer's disease.
Neurobiology of disease · July 15, 2014 · Animal study · cited 83 times · open access
PMID 25046994 · DOI 10.1016/j.nbd.2014.07.001 · Animal studies
- Rescue of cognitive-aging by administration of a neurogenic and/or neurotrophic compound.
Neurobiology of aging · March 2, 2014 · Animal study · cited 48 times
PMID 24702821 · DOI 10.1016/j.neurobiolaging.2014.02.017 · Animal studies
- Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Alzheimer's research & therapy · June 27, 2017 · Animal study · cited 31 times · open access
PMID 28655344 · DOI 10.1186/s13195-017-0273-7 · Animal studies
- Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
Scientific reports · April 3, 2017 · Animal study · cited 27 times · open access
PMID 28368015 · DOI 10.1038/srep45561 · Animal studies
Latest publications
- Diffusion MRI measures detect brain microstructure changes due to early treatment with neurotrophic peptide mimetic P021 in the 3xTg-AD mouse model of Alzheimer's disease.
Magnetic resonance imaging · February 23, 2026 · Animal study · cited 0 times · open access
PMID 41740658 · DOI 10.1016/j.mri.2026.110641 · Animal studies
- Effects of a ciliary neurotrophic factor (CNTF) small-molecule peptide mimetic in an in vitro and in vivo model of CDKL5 deficiency disorder.
Journal of neurodevelopmental disorders · November 26, 2024 · Animal study · cited 1 times · open access
PMID 39592934 · DOI 10.1186/s11689-024-09583-4 · Animal studies
- Alzheimer's Disease: Challenges and a Therapeutic Opportunity to Treat It with a Neurotrophic Compound.
Biomolecules · October 2, 2022 · Review · cited 25 times · open access
PMID 36291618 · DOI 10.3390/biom12101409 · Reviews and meta-analyses
- Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Journal of Alzheimer's disease : JAD · January 1, 2021 · Animal study · cited 17 times · open access
PMID 34057082 · DOI 10.3233/jad-201599 · Animal studies
- Prenatal to early postnatal neurotrophic treatment prevents Alzheimer-like behavior and pathology in mice.
Alzheimer's research & therapy · August 27, 2020 · Animal study · cited 13 times · open access
PMID 32854771 · DOI 10.1186/s13195-020-00666-7 · Animal studies
- Inhibition of AMD-Like Pathology With a Neurotrophic Compound in Aged Rats and 3xTg-AD Mice.
Frontiers in aging neuroscience · November 19, 2019 · Animal study · cited 12 times · open access
PMID 31803044 · DOI 10.3389/fnagi.2019.00309 · Animal studies
- Prevention of dendritic and synaptic deficits and cognitive impairment with a neurotrophic compound.
Alzheimer's research & therapy · June 27, 2017 · Animal study · cited 31 times · open access
PMID 28655344 · DOI 10.1186/s13195-017-0273-7 · Animal studies
- Early neurotrophic pharmacotherapy rescues developmental delay and Alzheimer's-like memory deficits in the Ts65Dn mouse model of Down syndrome.
Scientific reports · April 3, 2017 · Animal study · cited 27 times · open access
PMID 28368015 · DOI 10.1038/srep45561 · Animal studies
- Prevention of Amyloid-β and Tau Pathologies, Associated Neurodegeneration, and Cognitive Deficit by Early Treatment with a Neurotrophic Compound.
Journal of Alzheimer's disease : JAD · January 1, 2017 · Animal study · cited 20 times
PMID 28387677 · DOI 10.3233/jad-170075 · Animal studies
- Neurotrophic factor small-molecule mimetics mediated neuroregeneration and synaptic repair: emerging therapeutic modality for Alzheimer's disease.
Molecular neurodegeneration · July 11, 2016 · Review · cited 116 times · open access
PMID 27400746 · DOI 10.1186/s13024-016-0119-y · Reviews and meta-analyses
How this is counted
PubMed records matched by the names below, counted when the peptide is in the title, indexed by MeSH, or confirmed from the abstract. The exact query can be rerun on Europe PMC. Methodology
Search terms: P021 (with cntf or ciliary neurotrophic or neurotrophic or neurogenesis or alzheimer); Peptide 021 (with cntf or ciliary neurotrophic or neurotrophic)
(((TITLE_ABS:"P021" OR TITLE_ABS:"P 021") AND (TITLE_ABS:"cntf" OR TITLE_ABS:"ciliary neurotrophic" OR TITLE_ABS:"neurotrophic" OR TITLE_ABS:"neurogenesis" OR TITLE_ABS:"alzheimer")) OR ((TITLE_ABS:"Peptide 021" OR TITLE_ABS:"Peptide021") AND (TITLE_ABS:"cntf" OR TITLE_ABS:"ciliary neurotrophic" OR TITLE_ABS:"neurotrophic"))) AND SRC:MED
Cite this page
Peptide Library. (2026, November 16). P21 (BDNF-mimetic peptide) research statistics (Version weekly-2026-11-15) [Statistic]. Peptide Library. https://peptidelibrary.app/research/peptides/p21